{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:38:35Z","timestamp":1793893115377,"version":"4.8.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,10,1]]},"abstract":"<jats:p>The National Marrow Donor Program (NMDP) maintains a registry of approximately 4 million volunteer unrelated donors for patients in need of a stem cell transplant. When several comparably HLA-matched volunteers are identified for a patient, various criteria are used to select a donor. A retrospective analysis of 6978 bone marrow transplantations facilitated by the NMDP from 1987 to 1999 was conducted to study the effects of various donor characteristics on recipient outcome. The evaluation addressed possible effects of donor age, cytomegalovirus serologic status, ABO compatibility, race, sex, and parity on overall and disease-free survival, acute and chronic graft-versus-host disease (GVHD), engraftment, and relapse. Age was the only donor trait significantly associated with overall and disease-free survival. Five-year overall survival rates for recipients were 33%, 29%, and 25%, respectively, with donors aged 18 to 30 years, 31 to 45 years, and more than 45 years (P\u2009=\u2009.0002). A similar effect was observed among HLA-mismatched cases (28%, 22%, and 19%, respectively). A race mismatch between recipient and donor did not affect outcome. The cumulative incidences of grade III or IV acute GVHD were 30%, 34%, and 34%, respectively, with donors aged 18 to 30 years, 31 to 45 years, and more than 45 years (P\u2009=\u2009.005). The corresponding incidences of chronic GVHD at 2 years were 44%, 48%, and 49% (P\u2009=\u20090.02). Recipients with female donors who had undergone multiple pregnancies had a higher rate of chronic GVHD than recipients with male donors (54% versus 44%;P &amp;lt; .0001). The use of younger donors may lower the incidence of GVHD and improve survival after bone marrow transplantation. Age should be considered when selecting among comparably HLA-matched volunteer donors.<\/jats:p>","DOI":"10.1182\/blood.v98.7.2043","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"2043-2051","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":631,"title":["Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age"],"prefix":"10.1182","volume":"98","author":[{"given":"Craig","family":"Kollman","sequence":"first","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W. S.","family":"Howe","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra H.","family":"Filipovich","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Hegland","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naynesh","family":"Kamani","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Kernan","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"King","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voravit","family":"Ratanatharathorn","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weisdorf","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Confer","sequence":"additional","affiliation":[{"name":"From the National Marrow Donor Program and the University of Minnesota, Minneapolis; Fred Hutchinson Cancer Research Center, Seattle, WA; Brigham and Women's Hospital, Boston, MA; Children's Hospital of Cincinnati, OH; Children's National Medical Center, Washington, DC; Memorial Sloan- Kettering Cancer Center, New York, NY; and the University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021216444972700_B1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJM198009043031007","article-title":"Transplantation of marrow from an unrelated donor to a patient with acute leukemia.","volume":"303","author":"Hansen","year":"1980","journal-title":"N Engl J Med."},{"key":"2020021216444972700_B2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00007890-199102000-00034","article-title":"Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.","volume":"51","author":"Beatty","year":"1991","journal-title":"Transplantation."},{"key":"2020021216444972700_B3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM199303043280901","article-title":"Analysis of 462 transplants from unrelated donors facilitated by the National Marrow Donor Program.","volume":"328","author":"Kernan","year":"1993","journal-title":"N Engl J Med."},{"key":"2020021216444972700_B4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V81.2.543.543","article-title":"Unrelated donor marrow transplantation for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program.","volume":"8","author":"McGlave","year":"1993","journal-title":"Blood."},{"key":"2020021216444972700_B5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJM199403243301206","article-title":"Bone marrow transplantation.","volume":"330","author":"Armitage","year":"1994","journal-title":"N Engl J Med."},{"key":"2020021216444972700_B6","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol."},{"key":"2020021216444972700_B7","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V90.8.2962","article-title":"Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia.","volume":"90","author":"Weisdorf","year":"1997","journal-title":"Blood."},{"key":"2020021216444972700_B8","first-page":"1122","article-title":"The origins and development of the National Marrow Donor Program.","volume":"7","author":"Zumwalt","year":"1993","journal-title":"Leukemia."},{"key":"2020021216444972700_B9","first-page":"172","article-title":"Standards of the National Marrow Donor Program.","volume":"33","author":"National Marrow Donor Program Standards Committee","year":"1993","journal-title":"Transfus Med Rev."},{"key":"2020021216444972700_B10","first-page":"30","article-title":"The U.S. National Marrow Donor Program.","volume":"16","author":"Perkins","year":"1994","journal-title":"Am J Pediatr Hematol Oncol."},{"key":"2020021216444972700_B11","first-page":"667","article-title":"The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.","volume":"82","author":"Petersdorf","year":"1993","journal-title":"Blood."},{"key":"2020021216444972700_B12","doi-asserted-by":"crossref","first-page":"15358","DOI":"10.1073\/pnas.93.26.15358","article-title":"Definition of HLA-DQ as a transplantation antigen.","volume":"93","author":"Petersdorf","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021216444972700_B13","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood.V89.5.1818","article-title":"Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.","volume":"89","author":"Petersdorf","year":"1997","journal-title":"Blood."},{"key":"2020021216444972700_B14","first-page":"518","article-title":"Graft-versus-host disease.","volume-title":"Hematopoietic Stem Cell Transplantation.","author":"Sullivan","year":"1999","edition":"2nd ed."},{"key":"2020021216444972700_B15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1399-0039.1999.530421.x","article-title":"Nomenclature for factors of the HLA system, 1998.","volume":"53","author":"Bodmer","year":"1999","journal-title":"Tissue Antigens."},{"key":"2020021216444972700_B16","first-page":"397","article-title":"Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique.","volume-title":"HLA 1991. Oxford","author":"Kimura","year":"1992"},{"key":"2020021216444972700_B17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"2020021216444972700_B18","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration.","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemther Rep."},{"key":"2020021216444972700_B19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med."},{"key":"2020021216444972700_B20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/01621459.1993.10476289","article-title":"On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data.","volume":"88","author":"Gaynor","year":"1993","journal-title":"J Am Stat Assoc."},{"key":"2020021216444972700_B21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion).","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B."},{"key":"2020021216444972700_B22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation.","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood."},{"key":"2020021216444972700_B23","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","article-title":"T-cell depletion of HLA-identical transplants in leukemia.","volume":"78","author":"Marmont","year":"1991","journal-title":"Blood."},{"key":"2020021216444972700_B24","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood.V79.10.2771.bloodjournal79102771","article-title":"Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?","volume":"79","author":"Horowitz","year":"1992","journal-title":"Blood."},{"key":"2020021216444972700_B25","first-page":"97","article-title":"1993 progress report from the International Bone Marrow Transplant Registry.","volume":"12","author":"Bortin","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"2020021216444972700_B26","first-page":"858","article-title":"Bone marrow transplantation for severe aplastic anemia: has outcome improved?","volume":"90","author":"Passweg","year":"1997","journal-title":"Blood."},{"key":"2020021216444972700_B27","first-page":"443","article-title":"Bone-marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.","volume":"7","author":"Ash","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"2020021216444972700_B28","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","article-title":"Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell\u2013depleted stem cell transplantation.","volume":"95","author":"Broers","year":"2000","journal-title":"Blood."},{"key":"2020021216444972700_B29","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V67.4.1162.1162","article-title":"Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.","volume":"67","author":"Miller","year":"1986","journal-title":"Blood."},{"key":"2020021216444972700_B30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1056\/NEJM199804023381405","article-title":"Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.","volume":"338","author":"Hansen","year":"1998","journal-title":"N Engl J Med."},{"key":"2020021216444972700_B31","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/00007890-199106000-00010","article-title":"Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.","volume":"51","author":"Weisdorf","year":"1991","journal-title":"Transplantation."},{"key":"2020021216444972700_B32","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.","volume":"80","author":"Nash","year":"1992","journal-title":"Blood."},{"key":"2020021216444972700_B33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bmt.1701423","article-title":"Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.","volume":"22","author":"Carlens","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"2020021216444972700_B34","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V94.4.1465","article-title":"Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.","volume":"94","author":"Przepiorka","year":"1999","journal-title":"Blood."},{"key":"2020021216444972700_B35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-199510270-00003","article-title":"Impact of racial genetic polymorphism upon the probability of finding an HLA-matched donor.","volume":"60","author":"Beatty","year":"1995","journal-title":"Transplantation."},{"key":"2020021216444972700_B36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bmj.309.6950.286","article-title":"Race, ethnicity, culture, and science.","volume":"309","author":"McKenzie","year":"1994","journal-title":"BMJ."},{"key":"2020021216444972700_B37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.7326\/0003-4819-125-8-199610150-00008","article-title":"The medicalization of race: scientific legitimization of a flawed social construct.","volume":"125","author":"Witzig","year":"1996","journal-title":"Ann Intern Med."},{"key":"2020021216444972700_B38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1537-2995.1999.39299154733.x","article-title":"ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation.","volume":"39","author":"Benjamin","year":"1999","journal-title":"Transfusion."},{"key":"2020021216444972700_B39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-198204000-00017","article-title":"ABO-incompatible marrow transplants.","volume":"33","author":"Bensinger","year":"1982","journal-title":"Transplantation."},{"key":"2020021216444972700_B40","first-page":"853","article-title":"Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.","volume":"15","author":"Mehta","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"2020021216444972700_B41","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","article-title":"Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.","volume":"89","author":"Sierra","year":"1997","journal-title":"Blood."},{"key":"2020021216444972700_B42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","article-title":"The aging immune system: primer and prospectus.","volume":"273","author":"Miller","year":"1996","journal-title":"Science."},{"key":"2020021216444972700_B43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/cimm.1993.1068","article-title":"Interleukin-7 responsiveness of B220+ B cell precursors from bone marrow decreases in aging mice.","volume":"147","author":"Jonsson","year":"1993","journal-title":"Cell Immunol."},{"key":"2020021216444972700_B44","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood.V85.7.1850.bloodjournal8571850","article-title":"B220\u2212 bone marrow progenitor cells from New Zealand black autoimmune mice exhibit an age-associated decline in Pre-B and B-cell generation.","volume":"85","author":"Merchant","year":"1995","journal-title":"Blood."},{"key":"2020021216444972700_B45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V91.1.75","article-title":"Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age.","volume":"91","author":"Stephan","year":"1998","journal-title":"Blood."},{"key":"2020021216444972700_B46","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/blood.V78.5.1347.1347","article-title":"Effect of age on second messenger generation in neutrophils.","volume":"78","author":"Lipschitz","year":"1991","journal-title":"Blood."},{"key":"2020021216444972700_B47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1701554","article-title":"B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome.","volume":"23","author":"Gross","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"2020021216444972700_B48","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood.V84.9.3212.3212","article-title":"Obstructive lung disease in children after allogeneic bone marrow transplantation.","volume":"84","author":"Schultz","year":"1994","journal-title":"Blood."},{"key":"2020021216444972700_B49","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1182\/blood.V96.13.4096","article-title":"Engraftment and survival after unrelated donor bone marrow transplantation: a report from the National Marrow Donor Program (NMDP).","volume":"96","author":"Davies","year":"2000","journal-title":"Blood."},{"key":"2020021216444972700_B50","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.V64.3.630.630","article-title":"Marrow harvesting from normal donors.","volume":"64","author":"Buckner","year":"1984","journal-title":"Blood."},{"key":"2020021216444972700_B51","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood.V86.4.1636.bloodjournal8641636","article-title":"Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome.","volume":"86","author":"Davies","year":"1995","journal-title":"Blood."},{"key":"2020021216444972700_B52","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood.V86.4.1606.bloodjournal8641606","article-title":"The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.","volume":"86","author":"Petersdorf","year":"1995","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/7\/2043\/1677436\/h8190102043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/7\/2043\/1677436\/h8190102043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:11:39Z","timestamp":1733703099000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/98\/7\/2043\/107101\/Donor-characteristics-as-risk-factors-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,1]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v98.7.2043","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10,1]]}}}